NewzA medical procedure traditionally used to treat high cholesterol in patients who are difficult to manage has been observed to simultaneously reduce levels of per- and polyfluoroalkyl substances (PFAS), commonly known as "forever chemicals," in the bloodstream. The discovery occurred during routine clinical application of the filtration technique, which has been utilized in hospital settings for several decades.
While the reduction of these synthetic compounds was noted during the cholesterol treatment process, researchers have not yet identified the specific mechanism responsible for the removal of PFAS. Further investigation is required to understand the interaction between the filtration method and these chemicals, as well as the potential implications for broader clinical use.
In-depth summary · AI, neutral